Single dose relative bioavailability of five formulations 3 days [clinicaltrials_resource:6d2c07a62c6b9c38ccdb5d7052a8a489]
Plasma GSK2251052 Cmax, AUC(0-t), AUC(0-Tau), and AUC (0-∞), as applicable, for each formulation.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Single dose relative bioavailability of five formulations 3 days [clinicaltrials_resource:6d2c07a62c6b9c38ccdb5d7052a8a489]
Plasma GSK2251052 Cmax, AUC(0-t), AUC(0-Tau), and AUC (0-∞), as applicable, for each formulation.
Bio2RDF identifier
6d2c07a62c6b9c38ccdb5d7052a8a489
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6d2c07a62c6b9c38ccdb5d7052a8a489
measure [clinicaltrials_vocabulary:measure]
Single dose relative bioavailability of five formulations
time frame [clinicaltrials_vocabulary:time-frame]
description
Plasma GSK2251052 Cmax, AUC(0- ...... licable, for each formulation.
identifier
clinicaltrials_resource:6d2c07a62c6b9c38ccdb5d7052a8a489
title
Single dose relative bioavailability of five formulations 3 days
@en
type
label
Single dose relative bioavaila ...... c07a62c6b9c38ccdb5d7052a8a489]
@en